A new hotspot for cyclooxygenase inhibition
Prostaglandins, or PGs, are critical players in such physiological housekeeping functions as the regulation of renal water and sodium metabolism, blood clotting, parturition, and stomach acid secretion. These potent lipid signaling molecules are derived from the oxygenation of arachidonic acid by prostaglandin endoperoxide H synthases 1 and 2, commonly called cyclooxygenase-1 and -2, or COX-1 and COX-2.
Abnormal changes in PG production contribute to disease pathologies including inflammation and cancer, so researchers view COX-1 and COX-2 as pharmacological targets. Indeed, nonselective nonsteroidal anti-inflammatory drugs, or NSAIDs, such as ibuprofen, inhibit both isoforms, while coxibs such as Celebrex selectively inhibit COX-2.
COX enzymes are sequence homodimers; each subunit consists of physically distinct cyclooxygenase and peroxidase active sites linked by a bridging heme moiety. In solution, the enzymes function as heterodimers, such that only one subunit is catalytically active at a time.
Structurally, COX-1 and COX-2 are virtually identical. However, subtle differences drive isoform-specific substrate specificity and inhibition. Among these are the substitutions of cyclooxygenase channel residues Ile-434, His-513 and Ile-523 in COX-1 for Val-434, Arg-513 and Val-523 in COX-2, which result in the formation of a unique side pocket and increased volume of the cyclooxygenase active site in COX-2. This side pocket, with Arg-513 at its base, has been exploited in the design of coxibs aimed at reducing the gastrointestinal side effects caused by conventional NSAIDs.
Many researchers focus on time-dependent inhibition of COX-2, working to identify the conformational changes that drive the transitions between the kinetically observable inhibitor binding states. These studies originally focused on the COX-2 side pocket, but recent molecular dynamics simulations identified a different region of the active site critical for aspirin and Celebrex to inhibit COX-2. These simulations identified rotation of the side chain of the residue Leu-531, opposite the side pocket, as a way to expand further the volume of the cyclooxygenase channel. Indeed, crystal structures of COX-2 have provided evidence for the existence of alternate rotamer conformations for this side chain when different ligands are bound.
To evaluate the importance of the conformational flexibility of the side chain of Leu-531, our research group generated L531F and L531N mutations and showed that these substitutions reduced aspirin and Celebrex’s inhibition of COX-2. Thus, expansion of the active site volume via the flexibility associated with the side chain of Leu-531 allows Celebrex to achieve a high-affinity binding state and facilitates formation of the initial noncovalent complex in the case of aspirin acetylation.
Deciphering the protein conformational motions associated with COX catalysis and inhibition is the next major frontier in studying this enzyme. If we understand how the binding of substrates, allosteric activators and inhibitors induce conformational motions to modulate COX activity, we will be closer to developing and repurposing drugs for maximum efficacy with minimal risks.
Enjoy reading ASBMB Today?
Become a member to receive the print edition monthly and the digital edition weekly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles
New class of antimicrobials discovered in soil bacteria
Scientists have mined Streptomyces for antibiotics for nearly a century, but the newly identified umbrella toxin escaped notice.
New study finds potential targets at chromosome ends for degenerative disease prevention
UC Santa Cruz inventors of nanopore sequencing hail innovative use of their revolutionary genetic-reading technique.
From the journals: JLR
How lipogenesis works in liver steatosis. Removing protein aggregates from stressed cells. Linking plasma lipid profiles to cardiovascular health. Read about recent papers on these topics.
Small protein plays a big role in viral battles
Nef, an HIV accessory protein, manipulates protein expression in extracellular vesicles, leading to improved understanding of HIV-1 pathogenesis.
Genetics studies have a diversity problem that researchers struggle to fix
Researchers in South Carolina are trying to build a DNA database to better understand how genetics affects health risks. But they’re struggling to recruit enough Black participants.
Scientists identify new function of learning and memory gene common to all mammalian brain cells
Findings in mice may steer search for therapies to treat brain developmental disorders in children with SYNGAP1 gene mutations.